These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29330543)

  • 41. Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity.
    Zaidman CM; Wang LL; Connolly AM; Florence J; Wong BL; Parsons JA; Apkon S; Goyal N; Williams E; Escolar D; Rutkove SB; Bohorquez JL;
    Muscle Nerve; 2015 Oct; 52(4):592-7. PubMed ID: 25702806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.
    Ropars J; Lempereur M; Vuillerot C; Tiffreau V; Peudenier S; Cuisset JM; Pereon Y; Leboeuf F; Delporte L; Delpierre Y; Gross R; Brochard S
    PLoS One; 2016; 11(9):e0161938. PubMed ID: 27622734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coinheritance of Noonan syndrome and Becker muscular dystrophy.
    Dinopoulos A; Papadopoulou A; Manta P; Kekou K; Kanelopoulos T; Fretzayas A; Kitsiou S
    Neuromuscul Disord; 2010 Jan; 20(1):61-3. PubMed ID: 19875288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular pathogenesis of Duchenne muscular dystrophy-related fibrosis].
    Ohlendieck K; Swandulla D
    Pathologe; 2017 Feb; 38(1):21-29. PubMed ID: 28097378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Xp21/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy.
    Trippe H; Wieczorek S; Kötting J; Kress W; Schara U
    Neuropediatrics; 2014 Oct; 45(5):333-5. PubMed ID: 25046452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
    Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy.
    Timmons JA; Larsson O; Jansson E; Fischer H; Gustafsson T; Greenhaff PL; Ridden J; Rachman J; Peyrard-Janvid M; Wahlestedt C; Sundberg CJ
    FASEB J; 2005 May; 19(7):750-60. PubMed ID: 15857889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation.
    Ebrahimzadeh-Vesal R; Teymoori A; Azimi-Nezhad M; Hosseini FS
    Gene; 2018 Feb; 644():1-3. PubMed ID: 29246534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis and management of Duchenne muscular dystrophy in a developing country over a 10-year period.
    Thong MK; Bazlin RI; Wong KT
    Dev Med Child Neurol; 2005 Jul; 47(7):474-7. PubMed ID: 15991868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular diagnosis of Duchenne muscular dystrophy.
    Nallamilli BR; Ankala A; Hegde M
    Curr Protoc Hum Genet; 2014 Oct; 83():9.25.1-29. PubMed ID: 25271841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?
    Helderman-van den Enden AT; van den Bergen JC; Breuning MH; Verschuuren JJ; Tibben A; Bakker E; Ginjaar HB
    Clin Genet; 2011 Mar; 79(3):236-42. PubMed ID: 21070212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delays in diagnosis of Duchenne muscular dystrophy: An evaluation of genotypic and sociodemographic factors.
    Counterman KJ; Furlong P; Wang RT; Martin AS
    Muscle Nerve; 2020 Jan; 61(1):36-43. PubMed ID: 31573675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4.
    Baskin B; Gibson WT; Ray PN
    Neuromuscul Disord; 2011 Mar; 21(3):178-82. PubMed ID: 21134752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.